Financial Results for the Quarter and Year ended 31.03.2026
Recommendation of Final Dividend
Financial Results
Outcome of BM
i) to consider and take on record the audited standalone and consolidated financial results of the company for the quarter and year ended 31st March 2026, ii) to recommend dividend, if any and iii) to transact any other matter as may be specified in the agenda.
Monitoring Agency Report for the quarter ended 31-03-2026
Newspaper Advertisement- Special Window for Re-lodgement of Transfer requests for physical shares
Press Release on landmark collaboration with WFNS Innovation and Time Medical International Ventures (India) Pvt Ltd, a WOS of Fischer Medical Ventures Limited.
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for Q4-31.03.2026.
| Particulars | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 20.79 | 10.12 | 39.66 | 11.75 | 49.17 | 23.44 | 86.31 | 101.10 | 97.73 |
| YOY Revenue Growth % | - | - | - | - | 136.49% | 131.65% | 117.64% | 760.49% | 98.74% |
| Other Income | 0.47 | 0.74 | 0.22 | 0.38 | 0.15 | 7.47 | 2.48 | 1.09 | 1.28 |
| Total Income | 21.26 | 10.86 | 39.88 | 12.13 | 49.32 | 30.91 | 88.79 | 102.18 | 99.01 |
| Total Expenses + | 18.51 | 10.70 | 39.50 | 11.88 | 47.41 | 20.62 | 71.48 | 80.94 | 101.26 |
| Cost of Materials Consumed | 15.74 | 0.00 | 0.00 | 0.00 | 0.00 | 7.58 | 0.15 | 0.00 | 62.09 |
| Employee Benefit Expense | 0.34 | 0.39 | 0.51 | 0.75 | 0.94 | 3.16 | 3.75 | 4.17 | 4.02 |
| Other Expenses | 1.48 | 1.29 | 2.53 | 2.97 | 6.42 | 3.48 | 53.62 | 26.47 | 24.24 |
| Operating Profit | 2.29 | -0.58 | 0.16 | -0.13 | 1.77 | 2.82 | 14.82 | 20.16 | -3.53 |
| OPM % | 11% | -5.7% | 0.4% | -1.1% | 3.6% | 12% | 17.2% | 19.9% | -3.6% |
| Profit Before Tax + | 2.75 | 0.16 | 0.38 | 0.25 | 1.81 | 10.29 | 17.30 | 21.25 | -2.25 |
| Tax Expense | 0.17 | 0.28 | 0.09 | 0.54 | 0.50 | 5.28 | 3.41 | 2.01 | 4.87 |
| Tax % | 6.1% | 171.7% | 23% | 217.5% | 27.6% | 51.3% | 19.7% | 9.5% | - |
| Profit After Tax | 2.59 | -0.12 | 0.29 | -0.29 | 1.31 | 5.01 | 13.90 | 19.23 | -7.12 |
| EPS (Basic) | 0.65 | 0.16 | 0.05 | -0.05 | 0.09 | 0.77 | 2.15 | 0.30 | -0.11 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 308.58 | 110.70 | 20.98 |
| YOY Revenue Growth % | 178.75% | 427.61% | - |
| Other Income | 12.31 | 1.49 | 0.50 |
| Total Income | 320.89 | 112.19 | 21.48 |
| Total Expenses + | 274.30 | 109.48 | 19.37 |
| Cost of Materials Consumed | 62.24 | 0.00 | 15.74 |
| Employee Benefit Expense | 15.09 | 2.58 | 0.38 |
| Other Expenses | 107.82 | 13.21 | 2.29 |
| Operating Profit | 34.27 | 1.22 | 1.61 |
| OPM % | 11.1% | 1.1% | 7.7% |
| Profit Before Exceptional | 46.58 | 2.71 | 2.11 |
| Exceptional Items | 0.00 | -0.49 | 0.00 |
| Profit Before Tax + | 46.58 | 2.22 | 2.11 |
| Tax Expense | 15.56 | 1.01 | 0.27 |
| Tax % | 33.4% | 45.7% | 12.9% |
| Profit After Tax | 31.02 | 1.21 | 1.84 |
| EPS (Basic) | 0.48 | 0.22 | 1.67 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| ASSETS | |||
| Non-Current Assets + | 258.26 | 92.08 | 15.92 |
| Property, Plant & Equipment | 12.48 | 14.43 | 9.35 |
| Capital Work in Progress | 2.93 | 1.11 | 0.00 |
| Non-Current Investments | 123.21 | 10.77 | 1.21 |
| Goodwill | 6.72 | 5.28 | 2.22 |
| Other Intangible Assets | 0.00 | 0.00 | 0.00 |
| Current Assets + | 413.74 | 365.29 | 70.41 |
| Inventories | 12.66 | 9.16 | 4.48 |
| Trade Receivables | 288.80 | 76.07 | 22.87 |
| Cash and Cash Equivalents | 11.89 | 104.26 | 0.95 |
| Current Investments | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | |||
| Total Equity | 386.58 | 337.87 | 81.12 |
| Equity Share Capital | 65.45 | 63.80 | 53.50 |
| Other Equity | 320.34 | 274.06 | 27.62 |
| Non-Current Liabilities | 27.39 | 37.94 | 1.38 |
| Current Liabilities | 258.03 | 81.57 | 3.82 |
| Total Liabilities | 285.42 | 119.50 | 5.20 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Cash from Operating Activities | -137.59 | -86.25 | -7.35 |
| Cash from Investing Activities | 10.45 | -125.36 | -31.39 |
| Cash from Financing Activities | 34.57 | 314.92 | 37.06 |
| Net Increase/Decrease in Cash | -92.57 | 103.31 | -1.68 |